108 research outputs found
Co-Ni/Al2O3 Catalysts for CO2 Methanation at Atmospheric Pressure
The methanation of carbon dioxide under atmospheric pressure on a Co-Ni/Al2O3 catalyst containing 5 wt% of metals prepared by the impregnation method was studied. Temperature of 95% conversion CO2 for all catalysts been studied falls into range 320-450°C at conditions of SV 100ml/min, 0.1 MPa pressure, and composition of feeding gas mixture CO2 â 2%, H2 â 55%, He â 43%. Methane selectivity was sufficiently high â up to 98%
Gauge copies in the Landau-DeWitt gauge: a background invariant restriction
The Landau background gauge, also known as the Landau-DeWitt gauge, has found
renewed interest during the past decade given its usefulness in accessing the
confinement-deconfinement transition via the vacuum expectation value of the
Polyakov loop, describable via an appropriate background. In this Letter, we
revisit this gauge from the viewpoint of it displaying gauge (Gribov) copies.
We generalize the Gribov-Zwanziger effective action in a BRST and background
invariant way; this action leads to a restriction on the allowed gauge
fluctuations, thereby eliminating the infinitesimal background gauge copies.
The explicit background invariance of our action is in contrast with earlier
attempts to write down and use an effective Gribov-Zwanziger action. It allows
to address certain subtleties arising in these earlier works, such as a
spontaneous and thus spurious Lorentz symmetry breaking, something which is now
averted.Comment: 14 pages. v2: version to appear in Phys.Lett.B, with minor
modifications and extra reference
Recommended from our members
A Poly-N-AcetylglucosamineâShiga Toxin Broad-Spectrum Conjugate Vaccine for Shiga Toxin-Producing Escherichia coli
ABSTRACT Many pathogens produce the ÎČ-(1â6)-linked poly-N-acetylglucosamine (PNAG) surface polysaccharide that is being developed as a broadly protective antimicrobial vaccine. However, it is unknown whether systemically injected PNAG vaccines or antibodies would provide protective immunity against pathogens confined to the gastrointestinal tract such as Shiga toxin (Stx)-producing Escherichia coli (STEC), an important group of gastrointestinal (GI) pathogens for which effective immunotherapeutics are lacking. To ascertain whether systemic IgG antibody to PNAG impacts this infectious situation, a vaccine consisting of a synthetic nonamer of nonacetylated PNAG, 9GlcNH2, conjugated to the Shiga toxin 1b subunit (9GlcNH2-Stx1b) was produced. Rabbit antibodies raised to the conjugate vaccine were tested for bacterial killing and toxin neutralization in vitro and protection against infection in infant mice. Cell surface PNAG was detected on all 9 STEC isolates tested, representing 6 STEC serogroups, including E. coli O157:H7. Antibody to the 9GlcNH2-Stx1b conjugate neutralized Stx1 potently and Stx2 modestly. For O157:H7 and O104:H4 STEC strains, antibodies elicited by the 9GlcNH2-Stx1b conjugate possessed opsonic killing and bactericidal activity. Following intraperitoneal injection, antibodies to both PNAG and Stx were needed for infant mouse protection against O157 STEC. These antibodies also mediated protection against the Stx2-producing O104:H4 strain that was the cause of a recent outbreak in Germany, although sufficient doses of antibody to PNAG alone were protective against this strain in infant mice. Our observations suggest that vaccination against both PNAG and Stx, using a construct such as the 9GlcNH2-Stx1b conjugate vaccine, would be protective against a broad range of STEC serogroups
Fucans, but Not Fucomannoglucuronans, Determine the Biological Activities of Sulfated Polysaccharides from Laminaria saccharina Brown Seaweed
Sulfated polysaccharides from Laminaria saccharina (new name: Saccharina latissima) brown seaweed show promising activity for the treatment of inflammation, thrombosis, and cancer; yet the molecular mechanisms underlying these properties remain poorly understood. The aim of this work was to characterize, using in vitro and in vivo strategies, the anti-inflammatory, anti-coagulant, anti-angiogenic, and anti-tumor activities of two main sulfated polysaccharide fractions obtained from L. saccharina: a) L.s.-1.0 fraction mainly consisting of O-sulfated mannoglucuronofucans and b) L.s.-1.25 fraction mainly composed of sulfated fucans. Both fractions inhibited leukocyte recruitment in a model of inflammation in rats, although L.s.-1.25 appeared to be more active than L.s.-1.0. Also, these fractions inhibited neutrophil adhesion to platelets under flow. Only fraction L.s.-1.25, but not L.s.-1.0, displayed anticoagulant activity as measured by the activated partial thromboplastin time. Investigation of these fractions in angiogenesis settings revealed that only L.s.-1.25 strongly inhibited fetal bovine serum (FBS) induced in vitro tubulogenesis. This effect correlated with a reduction in plasminogen activator inhibitor-1 (PAI-1) levels in L.s.-1.25-treated endothelial cells. Furthermore, only parent sulfated polysaccharides from L. saccharina (L.s.-P) and its fraction L.s.-1.25 were powerful inhibitors of basic fibroblast growth factor (bFGF) induced pathways. Consistently, the L.s.-1.25 fraction as well as L.s.-P successfully interfered with fibroblast binding to human bFGF. The incorporation of L.s.-P or L.s.-1.25, but not L.s.-1.0 into Matrigel plugs containing melanoma cells induced a significant reduction in hemoglobin content as well in the frequency of tumor-associated blood vessels. Moreover, i.p. administrations of L.s.-1.25, as well as L.s.-P, but not L.s.-1.0, resulted in a significant reduction of tumor growth when inoculated into syngeneic mice. Finally, L.s.-1.25 markedly inhibited breast cancer cell adhesion to human platelet-coated surfaces. Thus, sulfated fucans are mainly responsible for the anti-inflammatory, anticoagulant, antiangiogenic, and antitumor activities of sulfated polysaccharides from L. saccharina brown seaweed
1,3,2-DIAZAPHOSPHORINANES. IV. PREPARATION AND CONVERSIONS OF 4-OXO-1,3,2-DIAZAPHOSPHORINANES
Synthetic hexasaccharide of the capsular polysaccharide of S. pneumoniae type 14 induces cytokines
- âŠ